Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 35: 913-917, 1989;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strasburger, C.
Right arrow Articles by Kohen, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strasburger, C.
Right arrow Articles by Kohen, F.

Clinical Chemistry, Vol 35, 913-917, Copyright © 1989 by American Association for Clinical Chemistry

Somatotropin as measured by a two-site time-resolved immunofluorometric assay

C Strasburger, G Barnard, L Toldo, B Zarmi, Z Zadik, A Kowarski and F Kohen
Department of Hormone Research, Weizmann Institute of Science, Rehovot, Israel.

To date, many of the current criteria for diagnosis of somatotropin (growth hormone, GH) deficiency have been based upon measurement of this hormone by competitive radioimmunoassay (RIA) with use of polyclonal antibodies. In recent years, however, the development of hybridoma technology has led to the generation of various monoclonal antibodies (Mabs) to GH with different affinities and epitope specificities. Subsequently, these reagents have been used in the development of noncompetitive two-site immunometric assays (e.g., immunoradiometric assay; IRMA). In general, the values obtained for serum GH by IRMA have been lower than those obtained by RIA, because of the epitope-specificity profile of the Mabs in the IRMA. Attempting to obtain GH values numerically similar to those by RIA, we used a combination of Mabs to GH in developing and evaluating a two-site time- resolved immunofluorometric assay (IFMA) based on the streptavidin- biotin interaction. Fluorescence is proportional to concentration of analyte and is linearly related to concentration over the range 0.3 to 40 micrograms/L. The assay was satisfactory with respect to sensitivity, accuracy, and precision (CV less than 10% over the entire working range). In addition, the concentration of GH was determined by the IFMA and a competitive RIA in serum obtained from GH deficient and acromegalic patients. The pairing of antibodies in the IFMA gave numerical values that agreed well with those by RIA (r = 0.97; n = 100).


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Clin. Endocrinol. Metab.Home page
J. Sauer, U. Renner, U. Hopfner, M. Lange, A. Müller, C. J. Strasburger, U. Pagotto, E. Arzt, and G. K. Stalla
Interleukin-1{beta} Enhances Interleukin-1 Receptor Antagonist Content in Human Somatotroph Adenoma Cell Cultures
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2429 - 2434.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Eliakim, J. A. Brasel, S. Mohan, W. L. T. Wong, and D. M. Cooper
Increased physical activity and the growth hormone-IGF-I axis in adolescent males
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R308 - R314.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
M. Hornum, D. M. Cooper, J. A. Brasel, A. Bueno, and K. E. Sietsema
Exercise-induced changes in circulating growth factors with cyclic variation in plasma estradiol in women
J Appl Physiol, June 1, 1997; 82(6): 1946 - 1951.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Association for Clinical Chemistry.